Pharmacokinetics of antitumor drugs: fundamental and clinical aspects

This work was supported by the Ministry of Science and Higher Education of the Russian Federation, subsidy agreement No. 075-15-2021-1060 dated 09.28.2021

The monograph provides an overview of fundamental and clinical research on the influence of genetic polymorphisms on the effectiveness of anticancer drugs, and also describes the results of a comparative analysis of the level of representation of pharmacogenetic information in clinical recommendations and instructions for the medical use of anticancer drugs in Russia and other countries of the world. A number of problems have been identified and options for the development of pharmacogenetics and personalized medicine in the Russian Federation have been proposed.

The book is intended for researchers and practicing doctors of various specialties, for students of medical and biological universities.